 Zynerba Pharmaceuticals Inc NASDAQ:ZYNE, the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters at the Society of Biological Psychiatry SOBP 2021 Virtual Meeting. Both posters will be made available on the Zynerba corporate website. 